Epigenetics Involvement in Breast Cancer
- 15 May 2022
- book chapter
- Published by Springer Nature
- p. 145-183
Abstract
No abstract availableKeywords
This publication has 179 references indexed in Scilit:
- Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer DetectionInternational Journal of Molecular Sciences, 2013
- Long noncoding RNAs and the genetics of cancerBritish Journal of Cancer, 2013
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistanceDrug Resistance Updates, 2012
- High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancerBreast Cancer Research and Treatment, 2011
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancerBritish Journal of Cancer, 2011
- Epigenetic targets of bioactive dietary components for cancer prevention and therapyClinical Epigenetics, 2010
- Characterization of human epigenomesCurrent Opinion in Genetics & Development, 2009
- Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAsCell, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005